AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Egetis Therapeutics

Major Shareholding Notification Nov 6, 2020

3152_iss_2020-11-06_ac384d4e-ea06-4e96-b382-632fe1dc4cde.pdf

Major Shareholding Notification

Open in Viewer

Opens in native device viewer

Issuer Egetis Therapeutics AB (publ)

Holder

RegulaPharm AB

Instrument

Instrument Aktie SE0003815604
Before the transaction
Shares 0
Voting rights 0
Transaction
Reason for major shareholding notification New share issue
Date 06/11/2020
Limit for number of shares 5 %
Limit for number of votes 5 %
After the transaction
Quantity
Shares 9,846,730
Directly held voting rights 9,846,730
Indirectly held voting rights 0
Percentage
Directly held shares 8.39 %
Directly held voting rights 8.39 %
Indirectly held voting rights 0 %

Resulting distribution of total holdings

Percentage of voting
rights:
Number of underlying
shares:
Shares 8.39 % 9,846,730
Instruments - FITA Ch. 4, section 2, first
paragraph, line 2
Instruments - FITA Ch. 4, section 2,
first paragraph, line 3
- Physically settled
- Cash settled
Total 8.39 % 9,846,730
Published
06/11/2020 13:58
Contact
Name
Christian Meijling
Phone
+46733290543
Email [email protected]

CLOSE PRINT

[email protected] Tfn 08-408 980 37 Fax 08-24 39 25

Talk to a Data Expert

Have a question? We'll get back to you promptly.